Tracy Warren

An investor, executive, and entrepreneur, Ms. Warren co-founded NellOne Therapeutics, a soft-tissue regenerative medicine company based on the NELL1 gene based on work initiated at Oak Ridge National Laboratory by her co-founder, Dr. Cymbeline Culiat. As founding CEO, she leads the company’s efforts with respect to strategy, fundraising, business development and licensing for its equine and human therapies.

Having spent over a decade commercializing technologies from nation’s leading institutions, Tracy serves on the Boards of Children’s Research Institute (CRI) at Children’s National Medical Center (Washington, DC) and Clemson University Research Foundation, and is a member of the Business Advisory Council to the Sheikh Zayed Institute for Pediatric Surgical Innovation. In addition to her investment activities, she also provides early-stage leadership to other businesses, currently serving as a general partner of Astarte Ventures, an early stage venture firm focused exclusively on women’s and children’s health and wellbeing.